Medicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

6M ago

PremiumPress Releases

Medicenna Announces Nasdaq Delisting and Cutback of Management Team

6M ago

MDNA

PremiumThe Fly

Medicenna Therapeutics CFO Jeff Caravella, CBO Brent Meadows depart

6M ago

MDNA

PremiumThe Fly

Medicenna Therapeutics reduces size of management team, U.S. presence

6M ago

MDNA

PremiumThe Fly

Medicenna Therapeutics to seek listing of common shares on OTC Markets

6M ago

MDNA

PremiumThe Fly

Medicenna Therapeutics announces Nasdaq delisting

6M ago

MDNA

More TSE:MDNA News >

MDNA News on the Web

No news articles were found for MDNA

News Score - Last 7 Days

Neutral

MDNA

Sector Average

Media Buzz

This Week3 articles

Weekly Average2.25 articles

News Sentiment

This Week100%

Sector Average66%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

Not enough data to generate Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MDNA’s Media Buzz Sentiment?

3 articles about MDNA were published this week. In an average week, 2.25 articles are published.

What is MDNA’s weekly average amount of articles?

In an average week, 2.25 articles about MDNA are published.

What is MDNA’s News Sentiment?

100% of articles about MDNA were positive this week, compared to its sector average of 66%.

Healthcare Stocks that are Trending in the News

PRVAPrivia Health Group

KRYSKrystal Biotech

CLDXCelldex

NHTCNatural Health Trends

SIBNSI-Bone

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing